| Role of soil microbiome and enzyme activities in plant growth nutrition and ecological restoration of soil health E Jamir, RD Kangabam, K Borah, A Tamuly, HP Deka Boruah, Y Silla Microbes and enzymes in soil health and bioremediation, 99-132, 2019 | 19 | 2019 |
| Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV H Sarma, E Jamir, GN Sastry Journal of Molecular Structure 1257, 132602, 2022 | 15 | 2022 |
| Applying polypharmacology approach for drug repurposing for SARS-CoV2 E Jamir, H Sarma, L Priyadarsinee, S Nagamani, K Kiewhuo, AS Gaur, ... Journal of Chemical Sciences 134 (2), 57, 2022 | 13 | 2022 |
| Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach SS Madugula, S Nagamani, E Jamir, L Priyadarsinee, GN Sastry Molecular Diversity 26 (3), 1675-1695, 2022 | 9 | 2022 |
| Structure-function relationships among selected human coronaviruses E Jamir, K Kiewhuo, L Priyadarsinee, H Sarma, S Nagamani, GN Sastry NIScPR-CSIR, India, 2022 | 7 | 2022 |
| OSADHI–An online structural and analytics based database for herbs of India K Kiewhuo, D Gogoi, HJ Mahanta, RK Rawal, D Das, S Vaikundamani, ... Computational Biology and Chemistry 102, 107799, 2023 | 4 | 2023 |
| In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination H Sarma, K Kiewhuo, E Jamir, GN Sastry Biophysical Chemistry 300, 107070, 2023 | 3 | 2023 |
| Polypharmacology guided drug repositioning approach for SARS-CoV2 E Jamir, H Sarma, L Priyadarsinee, K Kiewhuo, S Nagamani, GN Sastry Plos one 18 (8), e0289890, 2023 | 3 | 2023 |
| Molecular Property Diagnostic Suite Compound Library (MPDS-CL): a structure-based classification of the chemical space L John, S Nagamani, HJ Mahanta, S Vaikundamani, N Kumar, A Kumar, ... Molecular Diversity, 1-17, 2023 | 2 | 2023 |
| Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): An open access disease specific drug discovery portal GN Sastry, L Priyadarsinee, E Jamir, S Nagamani, HJ Mahanta, N Kumar, ... bioRxiv, 2023.08. 29.555437, 2023 | 1 | 2023 |
| Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): an open-source disease-specific drug discovery portal L Priyadarsinee, E Jamir, S Nagamani, HJ Mahanta, N Kumar, L John, ... GigaByte 2024, 2024 | | 2024 |
| Screening of phytochemicals for potential breast cancer targets BRCA1 and BARD1: A network pharmacology approach K Kiewhuo, E Jamir, L Priyadarsinee, S Nagamani, GN Sastry NIScPR-CSIR, India, 2023 | | 2023 |
| A structure-based drug repurposing approach by considering the twenty four SARS-CoV2 Targets: A consensus scoring approach E Jamir, H Sarma, L Priyadarsinee, K Kiewhuo, S Nagamani, GN Sastry | | 2022 |
G. Narahari SastryCSIR-NEISTVerified email at neist.res.in
